Dara (DARA) Pens Exclusive Agreement with Uman for US Commercialization Rights to Gemcitabine
Tweet
Share
E-mailGet Alerts DARA Hot Sheet
Join SI Premium – FREE
Dara Biosciences (Nasdaq: DARA) signs exclusive agreement with Uman Pharma for US commercialization rights to Gemcitabine. Said Uman plans to file ANDA for the product.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Solowin Holdings marks 10 years, expands into stablecoins and AI
- loanDepot receives NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
